The adenoviral E1A oncoproteins interfere with the growth-inhibiting effect of the cdk-inhibitor p21(CIP1/WAF1)

References

1. Arany Z., Sellers W. R., Livingston D. M., Eckner R. 1994; E1A associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799–800
   [Google Scholar]
2. Arany Z., Newsome D., Oldread E., Livingston D. M., Eckner R. 1995; A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374:81–84
   [Google Scholar]
3. Buchou T., Kranenburg O., van Dam H., Roelen D., Zantema A., Hall F. L., van der Eb A. J. 1993; Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines. Oncogene 8:1765–1773
   [Google Scholar]
4. Chan F. K., Zhang J., Cheng L., Shapiro D. N., Winoto A. 1995; Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4. Molecular and Cellular Biology 15:2682–2688
   [Google Scholar]
5. Datto M. B., Hu P. P., Kowalik T. F., Yingling J., Wang X. 1997; The viral oncoprotein E1A blocks transforming growth factor β-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Molecular and Cellular Biology 17:2030–2037
   [Google Scholar]
6. Dorsman J. C., Hagmeyer B. M., Veenstra J., Elfferich P., Nabben N., Zantema A., van der Eb A. J. 1995; The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains. Journal of Virology 69:2962–2967
   [Google Scholar]
7. Eckner R., Ewen M. E., Newsom D., Gerdes M., DeCaprio J. A., Lawrence J. B., Livingston D. M. 1994; Molecular cloning and functional analysis of the adenovirus E1A-associated 300kD protein (p300) reveals a protein with properties of a transcriptional adapter. Genes & Development 8:869–884
   [Google Scholar]
8. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. 1993; WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825
   [Google Scholar]
9. Elledge S. J., Winston J., Harper J. W. 1996; A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends in Cell Biology 6:388–392
   [Google Scholar]
10. Ewen M. E., Wing Y. G., Lawrence J. B., Livingston D. M. 1991; Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155–1164
    [Google Scholar]
11. Faha B., Harlow E., Lees E. 1993; The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2. Journal of Virology 67:2456–2465
    [Google Scholar]
12. Flores-Rozas H., Kelman Z., Dean F. B., Pan Z. Q., Harper J. W., Elledge S. J., O’Donnel M., Hurwitz J. 1994; Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proceedings of the National Academy of Sciences, USA 91:8655–8659
    [Google Scholar]
13. Fotedar R., Fitzgerald P., Rousselle T., Cannella D., DorJe M., Messier H., Fotedar A. 1996; p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene 12:2155–2164
    [Google Scholar]
14. Funk J. O., Waga S., Harry J. B., Espling E., Stillman B., Galloway D. A. 1997; Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes & Development 11:2090–2100
    [Google Scholar]
15. Götz C., Wagner P., Issinger O. G., Montenarh M. 1996; p2lWAFl/CIPl interacts with protein kinase CK2. Oncogene 13:391–398
    [Google Scholar]
16. Gu Y., Turck C. W., Morgan D. O. 1993; Inhibition of cdk2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707–710
    [Google Scholar]
17. Guan K. L., Jenkins C. W., Li Y., Nichols M. A., Wu X., O’Keefe C. L., Matera A. G., Xiong Y. 1994; Growth suppression by p18, a p16lNK4A/MTS1- and p14lNK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes & Development 8:2939–2952
    [Google Scholar]
18. Hannon G. J., Beach D. 1994; P15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257–260
    [Google Scholar]
19. Hannon G. J., Demetrick D., Beach D. 1993; Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes & Development 7:2378–2391
    [Google Scholar]
20. Harlow E., Lane D. 1988 Antibodies: A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
21. Harlow E., Franza B. R. Jr, Schley C. 1985; Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. Journal of Virology 55:533–546
    [Google Scholar]
22. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. 1993; The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816
    [Google Scholar]
23. Hunter T., Pines J. 1994; Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79:573–582
    [Google Scholar]
24. Jansen-Durr P. 1996; How viral oncogenes make the cell cycle. Trends in Genetics 12:270–275
    [Google Scholar]
25. Jones D. L., Münger K. 1997; Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. Journal of Virology 71:2905–2912
    [Google Scholar]
26. Jones D. L., Alani R. M., Münger K. 1997; The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes & Development 11:2101–2111
    [Google Scholar]
27. Kranenburg O., de Groot R. P., van der Eb A. J., Zantema A. 1995; Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene 10:87–95
    [Google Scholar]
28. Lee M. H., Reynisdottir I., Massagu J. J. 1995; Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Development 9:639–649
    [Google Scholar]
29. Li Y., Graham C., Lacy S., Duncan A. M., Whyte P. 1993; The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes & Development 7:2366–2377
    [Google Scholar]
30. Lukas J., Parry D., Aagaard L., Mann D. J., Bartkova J., Strauss M., Peters G., Bartek J. 1995; Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503–506
    [Google Scholar]
31. Lundblad J. R., Kwok R. P., Laurance M. E., Harter M. L., Goodman R. H. 1995; Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85–88
    [Google Scholar]
32. Luo Y., Hurwitz J., Massagu J. J. 1995; Cell-cycle inhibition by independent CDK and PCNA binding domains in p21^Clpl . Nature 375:159–161
    [Google Scholar]
33. Mal A., Poon R. Y., Howe P. H., Toyoshima H., Hunter T., Hartel M. L. 1996; Inactivation of p27^Klpi by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380:262–265
    [Google Scholar]
34. Medema R. H., Herrera R. H., Lam F., Weinberg R. 1995; Growth suppression by p16^ink4 requires functional retinoblastoma protein. Proceedings of the National Academy of Sciences, USA 92:6289–6293
    [Google Scholar]
35. Missero C., Calautti E., Eckner R., Chin J., Tsai L. H., Livingston D. M., Dotto G. P. 1995; Involvement of the cell-cycle inhibitor Cip1 /WAF1 and the E1A-associated p300 protein in terminal differentiation. Proceedings of the National Academy of Sciences, USA 92:5451–5455
    [Google Scholar]
36. Moran E. 1994; Mammalian cell growth controls reflected through protein interactions with the adenovirus E1A gene products. Seminars in Virology 5:327–340
    [Google Scholar]
37. Moran E., Mathews M. B. 1987; Multiple functional domains in the adenovirus E1A gene. Cell 48:177–178
    [Google Scholar]
38. Morozov A., Shiyanov P., Barr E., Leiden J. M., Raychaudhuri P. 1997; Accumulation of human papillomavirus type 16 E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21. Journal of Virology 71:3451–3457
    [Google Scholar]
39. Nasmyth K., Hunt T. 1993; Cell cycle. Dams and sluices. Nature 366:634–635
    [Google Scholar]
40. Nevins J. R. 1992; E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–428
    [Google Scholar]
41. Noda A., Ning Y., Venable S. F., Pereira-Smith O. M., Smith J. R. 1994; Cloning of senescence cell-derived inhibitors of DNA synthesis using an expression screen. Experimental Cell Research 211:90–98
    [Google Scholar]
42. Nomura H., Sawada Y., Ohtaki S. 1998; Interaction of p27 with E1A and its effect on CDK kinase activity. Biochemical and Biophysical Research Communications 248:228–234
    [Google Scholar]
43. Offringa R., Gebel S., van Dam H., Timmers M., Smits A., Zwart R., Stein B., Bos J. L., van der Eb A. J., Herrlich P. 1990; A novel function of the transforming domain of E1a: repression of AP-1 activity. Cell 62:527–538
    [Google Scholar]
44. Peeper D. S., Zantema A. 1993; Adenovirus-E1A proteins transform cells by sequestering regulatory proteins. Molecular Biology Reporter 17:197–207
    [Google Scholar]
45. Peeper D. S., Zantema A., Dowdy S. F., van der Eb A. J. 1992; Expression, purification, and functional characterization of adenovirus 5 and 12 E1A proteins produced in insect cells. Virology 190:733–745
    [Google Scholar]
46. Peters G. 1994; Cell cycle. Stifled by inhibitors. Nature 371:204–205
    [Google Scholar]
47. Polyak K., Lee M., Erdjument-Bromage H., Koff A., Roberts J. M., Tempst P., Massagu J. J. 1994; Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66
    [Google Scholar]
48. Roest P. A. M., Roberts R. G., Sugino S., van Ommen G. B., den Dunnen J. T. 1993; Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Human Molecular Genetics 2:1719–1721
    [Google Scholar]
49. Ruesch M. N., Laimins L. A. 1997; Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. Journal of Virology 71:5570–5578
    [Google Scholar]
50. Schrier P. I., Van Den Elsen P. J., Hertoghs J. J., van der Eb A. J. 1979; Characterization of tumor antigens in cells transformed by fragments of adenovirus type 5 DNA. Virology 99:372–385
    [Google Scholar]
51. Serrano M., Hannon G. J., Beach D. 1993; A new regulatory motif in cell-cycle control causing specific inhibition of the cyclin D/cdk4. Nature 366:704–707
    [Google Scholar]
52. Sherr C. J. 1994; Cl phase progression: cycling on cue. Cell 79:551–555
    [Google Scholar]
53. Sherr C. J. 1996; Cancer cell cycles. Science 274:1672–1677
    [Google Scholar]
54. Shim J., Lee H., Park J., Kim H., Choi E. J. 1996; A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381:804–806
    [Google Scholar]
55. Somasundaram K., El-Deiry W. S. 1997; Inhibition of p53-mediated transactivation and cell cycle arrest by ElA through its p300/CBP-interacting region. Oncogene 14:1047–1057
    [Google Scholar]
56. Steegenga W. T., van Laar T., Ritico N., Mandarino A., Shvarts A., van der Eb A. J., Jochemsen A. G. 1996; Adenovirus E1A proteins inhibit activation of transcription by p53. Molecular and Cellular Biology 16:2101–2109
    [Google Scholar]
57. Toyoshima H., Hunter T. 1994; p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67–74
    [Google Scholar]
58. van der Eb A. J., Graham F. L. 1980; Assay of transforming activity of tumour virus DNAs. Methods in Enzymology 65:826–839
    [Google Scholar]
59. Waga S., Hannon G., Beach D., Stillman B. 1994; The p21inhibitor of cyclin dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574–578
    [Google Scholar]
60. Whyte P. K., Buchkovich K. J., Horowitz J. M., Friend S. H., Raybuck M., Weinberg R. A., Harlow E. 1988; Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124–129
    [Google Scholar]
61. Xiong Y., Zhang H., Beach D. 1993; Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes & Development 7:1572–1583
    [Google Scholar]
62. Zantema A., Fransen J. A., Davis-Olivier A., Ramaekers F. C., Vooijs G. P., DeLeys B., van der Eb A. J. 1985; Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology 142:44–58
    [Google Scholar]
63. Zerfass K., Spitkovsky D., Schulze A., Joswig S., Henglein B., Jansen-Durr P. 1996; Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107. Journal of Virology 70:2637–2642
    [Google Scholar]
64. Zieve G. W., Turnball D., Mullins J. M., McIntosh J. R. 1980; Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Experimental Cell Research 126:397–405
    [Google Scholar]